Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.010 GBP
−3.14 M GBP
396.00 K GBP
368.56 M
About THERACRYF PLC ORD GBP0.0025
Sector
Industry
CEO
Huw Jones
Website
Headquarters
Nether Alderley
Founded
2014
ISIN
GB00BSVYN304
FIGI
BBG007NTPDG2
TheraCryf Plc is a clinical stage drug development company, which engages in the development of focussing on oncology and neuropsychiatry. Its pipeline includes SFX-01: Breast cancer, SFX-01:neurodevelopmental disorders, and Other Programmes. The company was founded by Stephen Franklin in 2007 and is headquartered in Nether Alderley, CH.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TCF is 0.525 GBX — it hasn't changed in the past 24 hours. Watch THERACRYF PLC ORD GBP0.0025 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange THERACRYF PLC ORD GBP0.0025 stocks are traded under the ticker TCF.
TCF stock has risen by 2.94% compared to the previous week, the month change is a −8.70% fall, over the last year THERACRYF PLC ORD GBP0.0025 has showed a −98.83% decrease.
We've gathered analysts' opinions on THERACRYF PLC ORD GBP0.0025 future price: according to them, TCF price has a max estimate of 11.00 GBX and a min estimate of 11.00 GBX. Watch TCF chart and read a more detailed THERACRYF PLC ORD GBP0.0025 stock forecast: see what analysts think of THERACRYF PLC ORD GBP0.0025 and suggest that you do with its stocks.
TCF stock is 10.00% volatile and has beta coefficient of −0.28. Track THERACRYF PLC ORD GBP0.0025 stock price on the chart and check out the list of the most volatile stocks — is THERACRYF PLC ORD GBP0.0025 there?
Today THERACRYF PLC ORD GBP0.0025 has the market capitalization of 2.26 M, it has increased by 0.00% over the last week.
Yes, you can track THERACRYF PLC ORD GBP0.0025 financials in yearly and quarterly reports right on TradingView.
THERACRYF PLC ORD GBP0.0025 is going to release the next earnings report on May 26, 2025. Keep track of upcoming events with our Earnings Calendar.
TCF net income for the last half-year is −1.25 M GBP, while the previous report showed −1.68 M GBP of net income which accounts for 25.80% change. Track more THERACRYF PLC ORD GBP0.0025 financial stats to get the full picture.
No, TCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 9.00 employees. See our rating of the largest employees — is THERACRYF PLC ORD GBP0.0025 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERACRYF PLC ORD GBP0.0025 EBITDA is −3.32 M GBP, and current EBITDA margin is −896.21%. See more stats in THERACRYF PLC ORD GBP0.0025 financial statements.
Like other stocks, TCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERACRYF PLC ORD GBP0.0025 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERACRYF PLC ORD GBP0.0025 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERACRYF PLC ORD GBP0.0025 stock shows the sell signal. See more of THERACRYF PLC ORD GBP0.0025 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.